| Literature DB >> 31672958 |
Gil-Chun Park1, Deok-Bog Moon1, Sang-Hyun Kang1, Chul-Soo Ahn1, Shin Hwang1, Ki-Hun Kim1, Tae-Yong Ha1, Gi-Won Song1, Dong-Hwan Jung1, Yong-In Yoon1, Sung-Gyu Lee1.
Abstract
BACKGROUND Hepatic artery (HA) reconstruction in living donor liver transplantation (LDLT) is more technically demanding than deceased donor LT (DDLT) because of the small diameter and short HA stump of the partial liver graft. Hence, hepatic artery thrombosis (HAT) can occur infrequently even though the HA is reconstructed microscopically. HAT is closely related to graft failure and mortality. Therefore, HAT should be detected early and HA flow reconstituted using several arterial inflows. We successfully performed redo HA reconstruction in LDLT and report our management process and outcomes. MATERIAL AND METHODS The right gastroepiploic artery (RGEA) was used in 15 patients, previous native HA in 3, and interposition graft from the aorta in 1. All HA reconstructions were performed under a microscope using the end-to-end interrupted suture method. We reviewed technical feasibility, cause of hepatic artery revision (HAR), patency of redo HA flow, graft salvage rate, time of revision, biliary complications, and mortality. RESULTS Ten of 21 cases were salvage LT. Biliary complications developed in 6 cases. The mean interval of HAR with the RGEA was 1.5±1.2 postoperative days. All patients were alive without lethal complications of HAT during the mean follow-up period of 23.3 months. In the other 6 cases of HAR without using the RGEA, we performed redo HA reconstruction after thrombectomy with the native right HA (n=2), right gastric artery, left HA, gastroduodenal artery, and jump graft from the aorta (n=1, respectively). Among them, 3 died from biliary sepsis, graft dysfunction from large-sized ischemic injury, and pneumonia. CONCLUSIONS HAR with the RGEA is feasible for HAT management in LDLT patients without adequate hepatic arteries. When all inflows mentioned are unavailable, jump graft from the aorta using a cadaveric fresh iliac artery may be feasible.Entities:
Mesh:
Year: 2019 PMID: 31672958 PMCID: PMC6857352 DOI: 10.12659/AOT.919650
Source DB: PubMed Journal: Ann Transplant ISSN: 1425-9524 Impact factor: 1.530
Characteristics of the 21 patients who underwent HAR with RGEA and other inflows.
| Characteristics | RGEA group (n=15) | Non-RGEA group (n=6) | Comment |
|---|---|---|---|
| Sex | |||
| Male/Female | 11/4 (73.3%/26.7%) | 5/1 (83.3%/16.7%) | |
|
| |||
| Age, years | 58.7±7.1 | 58.0±7.8 | |
|
| |||
| Diagnosis | |||
| Viral hepatitis | 9 (60.0%) | 5 (83.3%) | |
| Alcoholic | 3 (20.0%) | 0 | |
| Others | 3 (20.0%) | 1 (16.7%) | |
|
| |||
| MELD score | 10.0±3.4 | 14.8±10.7 | |
|
| |||
| GRWR, % | 0.94±0.17 | 1.14±0.50 | |
|
| |||
| Mean follow up, mo | 23.3 (range, 1–41) | 9.5 (range, 3–18) | |
|
| |||
| HCC | |||
| Yes/no | 10 (66.7%)/5 (33.3%) | 3 (50%)/3 (50%) | |
|
| |||
| preLT therapy | |||
| TACE/RFA/Radiation | 10 (66.7%)/2 (13.3%)/1 (6.7%) | 3 ((50%)/0/0 | |
|
| |||
| Graft type | |||
| mRL/LL/dual/whole | 13 (86.7%)/1 (6.7%)/1 (6.7%)/0 | 4 (66.7%)/1 (16.7%)/0/1 (16.7%) | |
|
| |||
| Salvage | |||
| Yes/no | 5 (33.3%)/10 (66.7%) | 4 (66.7%)/2 (33.3%) | |
|
| |||
| Total Ischemic time, min | 133.2±33.4 | 169.0±104.4 | nonRGEA: 1 whole graft |
|
| |||
| Cause of HAR | |||
| HAT | 10 (66.7%) | 4 (66.7%) | |
| HAD | 4 (26.7%) | 1 (16.7%) | |
| Kinking/compression | 1 (6.7%)/0 | 0/1 (16.7%) | |
|
| |||
| Interval, day | 1.5±1.2 | 1.1±0.8 | |
|
| |||
| Method | |||
| Antegastric/retrogastric | 8 (53.3%)/7 (46.7%) | RGEA group only | |
|
| |||
| Number of bile duct | |||
| Single/double | 11 (73.3%)/4 (26.7%) | 5 (83.3%)/1 (16.7%) | |
|
| |||
| Type of anastomosis | |||
| Duct to duct | 12 (80%) | 3 (50%) | |
| Hepaticojejunostomy | 3 (20%) | 3 (50%) | |
|
| |||
| Biliary complications | |||
| Stricture | 5 (33.3%) | 0 | |
| Leak/biloma | 0 | 1 (16.7%) | |
|
| |||
| Hospital stay, day | 35.3±27.9 | 21.1±12.9 | |
|
| |||
| 90-day patient survival | 100% | 50% | |
|
| |||
| Mortality | 0 (0%) | 3 (50%) | Biliary sepsis, graft dysfunction, pneumonia |
HAR – hepatic artery revision; RGEA – right gastroepiploic artery; MELD – model for end-stage liver disease; GRWR – graft-recipient weight ratio; HCC – hepatocellular carcinoma; LT – liver transplantation; TACE – transcatheter arterial chemoembolization; RFA – radiofrequency ablation; mRL – modified right lobe; LL – left lobe; HAT – hepatic artery thrombosis; HAD – hepatic artery intimal dissection.
Different studies on the morbidity and mortality from HAT after LDLT.
| Incidence (n, %) | Morbidity (n, %) | Mortality | Comment | |
|---|---|---|---|---|
| Song S, et al. [ | 7/522 (1.3%) | 3 BS (42.8%) | 42.8% | |
| Bekker J, et al. [ | 4.4% | NS | 33.3% (range, 0–80%) | Review article |
| Uchiyama H, et al. [ | 2/335 (0.6%) | 1 BS (50%) 1 re-LT (50%) | No | |
| Wang CC, et al. [ | 3/126 (2.4%) | 1 bile leak (33.3%) 2 BS (66.6%) | No | |
| Lee JH, et al. [ | 2/463 (0.4%) | NS | 50% | |
| Current study | 14/1,232 (1.1%) | 5 BS (23.8%) | 3/1,232 (0.2%) |
BS – biliary stricture; NS – not stated; LT – liver transplantation.
Figure 1Follow-up dynamic computed tomography showing good patency of hepatic artery (HA) inflow after hepatic artery revision (HAR) using the right gastroepiploic artery (RGEA). According to the course of the RGEA, there are 2 methods for HAR: antegastric (A) and retrogastric (B).